Imperial College London

Prof Liz Lightstone

Faculty of MedicineDepartment of Immunology and Inflammation

Proconsul and Professor of Renal Medicine
 
 
 
//

Contact

 

+44 (0)20 3313 3152l.lightstone Website CV

 
 
//

Assistant

 

Miss Anjli Jagpal +44 (0)20 3313 3152

 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Publication Type
Year
to

226 results found

Beckwith H, Medjeral-Thomas N, Galliford J, Griffith M, Levy J, Lightstone L, Palmer A, Roufosse C, Cook HT, Cairns Tet al., 2014, Mycophenolate mofetil therapy in IgA nephropathy: histological changes after treatment, SCOTTISH MEDICAL JOURNAL, Vol: 59, Pages: E26-E26, ISSN: 0036-9330

Journal article

Lightstone L, 2014, Prepregnancy counselling and risk assessment: General overview, Renal Disease in Pregnancy, Pages: 22-29, ISBN: 9781904752592

Women with kidney disease have an increased risk of adverse maternal and fetal outcomes and it is now recognised that kidney disease is much more common than previously appreciated. By using an estimation of glomerular filtration rate (eGFR) rather than serum creatinine to assess renal function, between 3% and 10% of women of childbearing age might be defined as having chronic kidney disease (CKD). Physicians in both primary and secondary care need to be alert to advising women with renal disease that they might be at risk, but they need guidelines as to who to alert and how to advise on the degree of risk. This chapter will address these issues in more detail. The aim is to advise all women who are at increased risk of that risk prior to conception — not only so that appropriate investigations and medication changes can be implemented safely well in advance but to avoid the emotional trauma of only discovering, once pregnant, that pregnancy might be associated with long-term complications. Importantly, many women with kidney disease may be entirely unaware that their condition could affect a pregnancy. Who should have prepregnancy counselling? The role of prepregnancy advice is to make a woman and her partner aware of the risks a pregnancy may pose to her health and that of the fetus, to give guidance as to the best time to contemplate pregnancy (i.e. sooner, if she has progressive renal disease, or later, if she has a relapsing condition that has recently flared), and to provide the opportunity to optimise treatment to ensure she is not on teratogenic medications at the time of conception and to focus her on the need for optimal control of risk factors such as hypertension and hyperglycaemia.

Book chapter

Beckwith H, Lightstone L, 2014, Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis, NEPHRON CLINICAL PRACTICE, Vol: 128, Pages: 250-254, ISSN: 1660-2110

Journal article

Wilkinson E, Randhawa G, Hall M, Lightstone L, Farrington K, Greenwood R, Roderick P, Feehally Jet al., 2013, The impact of national chronic kidney disease management guidelines in the United Kingdom on referral patterns for South Asian and european patients with type 2 diabetes mellitus, Global Public Health Policy, Pages: 225-249, ISBN: 9781624177194

Background: South Asian patients with type 2 diabetes mellitus in the United Kingdom are over 10 times more likely to progress to end-stage renal disease than European patients. It is unclear whether this is due to late interaction with primary care, late referral to secondary care, suboptimal treatment with protective therapies or increased rates of progression among South Asian patients. This study investigated the demographic and clinical status of South Asian and European patients at the time of referral to renal service, before and after the introduction of national CKD management guidelines. The study also sought to understand patient experiences. Method: A mixed-methods approach was undertaken combining audit and patient interviews. The audit consisted of a retrospective, observational study comparing all South Asian and European patients with type 2 diabetes referred to 4 specialist renal services in the United Kingdom in 2004 and in 2007. Univariate and multivariate analyses were performed. For the patient interviews, newly referred South Asian and White European patients with diabetes over 16 years were recruited from nephrology outpatient clinics in three UK centres - Luton, West London and Leicester. A semi-structured qualitative interview was conducted with 48 patients and a thematic analysis of the data produced is reported. Results: The national audit shows that South Asian patients were younger than European patients at the time of referral (2004: European (E) 70.1±10.5 vs South Asian (SA) 63.0±12.1 years, p<0.001) with less advanced renal disease (2004: eGFR E 40.7±19.6 vs SA 47.3±24.8 ml/min, p=0.006). Following introduction of national CKD guidelines, patients were referred with more advanced renal disease although the decrease in mean eGFR was less pronounced for South Asian patients (2007: eGFR E 32.7±12.4 (- 8.0) vs SA 42.8±23.1 (-4.5) ml/min, p=0.001). These differences were not accounted for by pre

Book chapter

Arulkumaran N, Lightstone L, 2013, Severe pre-eclampsia and hypertensive crises, BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, Vol: 27, Pages: 877-884, ISSN: 1521-6934

Journal article

Griffin B, Lightstone L, 2013, Renoprotective strategies in lupus nephritis: beyond immunosuppression, LUPUS, Vol: 22, Pages: 1267-1273, ISSN: 0961-2033

Journal article

Condon MB, Ashby D, Pepper RJ, Cook HT, Levy JB, Griffith M, Cairns TD, Lightstone Let al., 2013, Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids, ANNALS OF THE RHEUMATIC DISEASES, Vol: 72, Pages: 1280-1286, ISSN: 0003-4967

Journal article

Bertsias G, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden J, Boletis J, Cervera R, Doerner T, Doria A, Ferrario F, Floege J, Houssiau F, Ioannidis JP, Isenberg D, Kallenberg CG, Lightstone L, Marks S, Martini A, Moroni G, Neumann I, Niaudet P, Praga M, Schneider M, Tesar V, Vasconcelos C, van Vollenhoven R, Zakharova E, Haubitz M, Gordon C, Jayne D, Boumpas Det al., 2013, JOINT EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ADULT AND PEDIATRIC LUPUS NEPHRITIS, ANNALS OF THE RHEUMATIC DISEASES, Vol: 71, Pages: 74-75, ISSN: 0003-4967

Journal article

Lightstone L, 2013, Minimising steroids in lupus nephritis - will B cell depletion pave the way?, LUPUS, Vol: 22, Pages: 390-399, ISSN: 0961-2033

Journal article

Bramham K, Chusney G, Lee J, Lightstone L, Nelson-Piercy Cet al., 2013, Breastfeeding and Tacrolimus: Serial Monitoring in Breast-Fed and Bottle-Fed Infants, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, Vol: 8, Pages: 563-567, ISSN: 1555-9041

Journal article

Wilkinson E, Randhawa G, Feehally J, Farrington K, Greenwood R, Choi P, Lightstone Let al., 2012, A multi-centre qualitative study exploring the experiences of UK South Asian and White Diabetic Patients referred for renal care, BMC NEPHROLOGY, Vol: 13

Journal article

Sundel R, Solomons N, Lisk L, 2012, Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial, LUPUS, Vol: 21, Pages: 1433-1443, ISSN: 0961-2033

Journal article

Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JHM, Boletis J, Cervera R, Doerner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JPA, Isenberg DA, Kallenberg CGM, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DTet al., 2012, Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis, ANNALS OF THE RHEUMATIC DISEASES, Vol: 71, Pages: 1771-1782, ISSN: 0003-4967

Journal article

Okada Y, Sim X, Go MJ, Wu J-Y, Gu D, Takeuchi F, Takahashi A, Maeda S, Tsunoda T, Chen P, Lim S-C, Wong T-Y, Liu J, Young TL, Aung T, Seielstad M, Teo Y-Y, Kim YJ, Lee J-Y, Han B-G, Kang D, Chen C-H, Tsai F-J, Chang L-C, Fann S-JC, Mei H, Rao DC, Hixson JE, Chen S, Katsuya T, Isono M, Ogihara T, Chambers JC, Zhang W, Kooner JS, Albrecht E, Yamamoto K, Kubo M, Nakamura Y, Kamatani N, Kato N, He J, Chen Y-T, Cho YS, Tai E-S, Tanaka Tet al., 2012, Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations, NATURE GENETICS, Vol: 44, Pages: 904-+, ISSN: 1061-4036

Journal article

Lawrence C, Cook HT, Lightstone L, 2012, Seasonal relapsing minimal change disease: a novel strategy for avoiding long-term immunosuppression., Case Rep Nephrol Urol, Vol: 2, Pages: 102-107

BACKGROUND: We describe the case of a young woman with seasonal allergic rhinitis who presented with signs of a lower respiratory tract infection, acute renal impairment and the nephrotic syndrome, demonstrated on biopsy to be due to minimal change disease (MCD) with acute tubular injury. Following initiation of high-dose corticosteroids, her respiratory symptoms and renal impairment improved, and the nephrotic syndrome went rapidly into remission, but relapsed, off treatment, in a seasonal fashion. MANAGEMENT: In view of significant side effects related to corticosteroids, relapses were treated with the calcineurin inhibitor tacrolimus with excellent effect, but the patient was keen to avoid the complications of medium-term immunosuppression and so the drug was weaned early. She relapsed for the second time, whilst off tacrolimus, at the same time of year as at her initial presentation. In subsequent years we have successfully managed this patient with seasonal relapsing MCD with seasonal prophylactic tacrolimus therapy. DISCUSSION: We discuss the natural history of MCD and treatment options and demonstrate the utility of a clear understanding of the natural history of the condition in order to predict disease relapse and tailor therapy to the individual patient.

Journal article

Bramham K, Lightstone L, 2012, Pre-pregnancy counseling for women with chronic kidney disease, JOURNAL OF NEPHROLOGY, Vol: 25, Pages: 450-459, ISSN: 1121-8428

Journal article

Lightstone L, 2012, The Landscape After LUNAR: Rituximab's Crater-Filled Path, ARTHRITIS AND RHEUMATISM, Vol: 64, Pages: 962-965, ISSN: 0004-3591

Journal article

Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons Net al., 2011, Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis, NEW ENGLAND JOURNAL OF MEDICINE, Vol: 365, Pages: 1886-1895, ISSN: 0028-4793

Journal article

Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang S-J, Pihur V, Vollenweider P, O'Reilly PF, Amin N, Bragg-Gresham JL, Teumer A, Glazer NL, Launer L, Zhao JH, Aulchenko Y, Heath S, Sober S, Parsa A, Luan J, Arora P, Dehghan A, Zhang F, Lucas G, Hicks AA, Jackson AU, Peden JF, Tanaka T, Wild SH, Rudan I, Igl W, Milaneschi Y, Parker AN, Fava C, Chambers JC, Fox ER, Kumari M, Go MJ, van der Harst P, Kao WHL, Sjogren M, Vinay DG, Alexander M, Tabara Y, Shaw-Hawkins S, Whincup PH, Liu Y, Shi G, Kuusisto J, Tayo B, Seielstad M, Sim X, Khanh-Dung HN, Lehtimaki T, Matullo G, Wu Y, Gaunt TR, Onland-Moret NC, Cooper MN, Platou CGP, Org E, Hardy R, Dahgam S, Palmen J, Vitart V, Braund PS, Kuznetsova T, Uiterwaal CSPM, Adeyemo A, Palmas W, Campbell H, Ludwig B, Tomaszewski M, Tzoulaki I, Palmer ND, Aspelund T, Garcia M, Chang Y-PC, O'Connell JR, Steinle NI, Grobbee DE, Arking DE, Kardia SL, Morrison AC, Hernandez D, Najjar S, McArdle WL, Hadley D, Brown MJ, Connell JM, Hingorani AD, Day INM, Lawlor DA, Beilby JP, Lawrence RW, Clarke R, Hopewell JC, Ongen H, Dreisbach AW, Li Y, Young JH, Bis JC, Kahonen M, Viikari J, Adair LS, Lee NR, Chen M-H, Olden M, Pattaro C, Bolton JAH, Koettgen A, Bergmann S, Mooser V, Chaturvedi N, Frayling TM, Islam M, Jafar TH, Erdmann J, Kulkarni SR, Bornstein SR, Graessler J, Groop L, Voight BF, Kettunen J, Howard P, Taylor A, Guarrera S, Ricceri F, Emilsson V, Plump A, Barroso IS, Khaw K-T, Weder AB, Hunt SC, Sun YV, Bergman RN, Collins FS, Bonnycastle LL, Scott LJ, Stringham HM, Peltonen L, Perola M, Vartiainen E, Brand S-M, Staessen JA, Wang TJ, Burton PR, Artigas MS, Dong Y, Snieder H, Wang X, Zhu H, Lohman KK, Rudock ME, Heckbert SR, Smith NL, Wiggins KL, Doumatey A, Shriner D, Veldre G, Viigimaa M, Kinra S, Prabhakaran D, Tripathy V, Langefeld CD, Rosengren A, Thelle DS, Corsi AM, Singleton A, Forrester T, Hilton G, McKenzie CA, Salako T, Iwai N, Kita Y, Ogihara T, Ohkubo T, Okamura T, Ueshimet al., 2011, Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk, NATURE, Vol: 478, Pages: 103-109, ISSN: 0028-0836

Journal article

Wain LV, Verwoert GC, O'Reilly PF, Shi G, Johnson T, Johnson AD, Bochud M, Rice KM, Henneman P, Smith AV, Ehret GB, Amin N, Larson MG, Mooser V, Hadley D, Doerr M, Bis JC, Aspelund T, Esko T, Janssens ACJW, Zhao JH, Heath S, Laan M, Fu J, Pistis G, Luan J, Arora P, Lucas G, Pirastu N, Pichler I, Jackson AU, Webster RJ, Zhang F, Peden JF, Schmidt H, Tanaka T, Campbell H, Igl W, Milaneschi Y, Hottenga J-J, Vitart V, Chasman DI, Trompet S, Bragg-Gresham JL, Alizadeh BZ, Chambers JC, Guo X, Lehtimaki T, Kuehnel B, Lopez LM, Polasek O, Boban M, Nelson CP, Morrison AC, Pihur V, Ganesh SK, Hofman A, Kundu S, Mattace-Raso FUS, Rivadeneira F, Sijbrands EJG, Uitterlinden AG, Hwang S-J, Vasan RS, Wang TJ, Bergmann S, Vollenweider P, Waeber G, Laitinen J, Pouta A, Zitting P, McArdle WL, Kroemer HK, Voelker U, Voelzke H, Glazer NL, Taylor KD, Harris TB, Alavere H, Haller T, Keis A, Tammesoo M-L, Aulchenko Y, Barroso I, Khaw K-T, Galan P, Hercberg S, Lathrop M, Eyheramendy S, Org E, Sober S, Lu X, Nolte IM, Penninx BW, Corre T, Masciullo C, Sala C, Groop L, Voight BF, Melander O, O'Donnell CJ, Salomaa V, d'Adamo AP, Fabretto A, Faletra F, Ulivi S, Del Greco FM, Facheris M, Collins FS, Bergman RN, Beilby JP, Hung J, Musk AW, Mangino M, Shin S-Y, Soranzo N, Watkins H, Goel A, Hamsten A, Gider P, Loitfelder M, Zeginigg M, Hernandez D, Najjar SS, Navarro P, Wild SH, Corsi AM, Singleton A, de Geus EJC, Willemsen G, Parker AN, Rose LM, Buckley B, Stott D, Orru M, Uda M, van der Klauw MM, Zhang W, Li X, Scott J, Chen Y-DI, Burke GL, Kahonen M, Viikari J, Doering A, Meitinger T, Davies G, Starr JM, Emilsson V, Plump A, Lindeman JH, 't Hoen PAC, Koenig IR, Felix JF, Clarke R, Hopewell JC, Ongen H, Breteler M, Debette S, DeStefano AL, Fornage M, Mitchell GF, Smith NL, Holm H, Stefansson K, Thorleifsson G, Thorsteinsdottir U, Samani NJ, Preuss M, Rudan I, Hayward C, Deary IJ, Wichmann H-E, Raitakari OT, Palmas W, Kooner JS, Stolk RP, Jukema JW, Wright AF, Boomsma DI, Bandinelli S, Gyllensteet al., 2011, Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure, NATURE GENETICS, Vol: 43, Pages: 1005-U122, ISSN: 1061-4036

Numerous genetic loci have been associated with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Europeans1,2,3. We now report genome-wide association studies of pulse pressure (PP) and mean arterial pressure (MAP). In discovery (N = 74,064) and follow-up studies (N = 48,607), we identified at genome-wide significance (P = 2.7 × 10−8 to P = 2.3 × 10−13) four new PP loci (at 4q12 near CHIC2, 7q22.3 near PIK3CG, 8q24.12 in NOV and 11q24.3 near ADAMTS8), two new MAP loci (3p21.31 in MAP4 and 10q25.3 near ADRB1) and one locus associated with both of these traits (2q24.3 near FIGN) that has also recently been associated with SBP in east Asians. For three of the new PP loci, the estimated effect for SBP was opposite of that for DBP, in contrast to the majority of common SBP- and DBP-associated variants, which show concordant effects on both traits. These findings suggest new genetic pathways underlying blood pressure variation, some of which may differentially influence SBP and DBP.

Journal article

Chusney GD, Bramham K, Nelson-Piercy C, Rosser C, James A, Cairns T, Lightstone L, Lee Jet al., 2011, Tacrolimus monitoring during breastfeeding in neonates of transplant recipients, 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: 476-476, ISSN: 0163-4356

Conference paper

Chusney GD, Lightstone L, Cairns T, Lee Jet al., 2011, Quantification of hydroxychloroquine in whole blood samples by LC-MS/MS, 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: 500-500, ISSN: 0163-4356

Conference paper

Wilkinson E, Randhawa G, Farrington K, Greenwood R, Feehally J, Choi P, Lightstone Let al., 2011, Lack of awareness of kidney complications despite familiarity with diabetes: a multi-ethnic qualitative study., J Ren Care, Vol: 37, Pages: 2-11

BACKGROUND: Comparing South Asians with White Europeans and examining the cultural context of any observed differences is a necessary step in achieving culturally competent services and in helping to reduce inequalities which exist in outcomes for South Asian patients with End Stage Renal Disease. METHODS: Newly referred South Asian and White adult patients with diabetes were recruited from nephrology outpatient clinics in three UK centres--Luton, West London and Leicester. A semi-structured qualitative interview was conducted with 48 patients and a thematic analysis of the data produced is reported. RESULTS: Access to knowledge about renal complications of diabetes, was related to referral to renal services and recent monitoring and not to previous medical encounters. South Asian patients were aware of the high prevalence of diabetes within South Asian communities and a small number reported experience of kidney problems in other family members although any connection with diabetes was not made. CONCLUSION: Ongoing renal care information should be provided to people with diabetes and the cultural context of any information exchange needs to be addressed.

Journal article

Lightstone L, 2011, Renal disease and pregnancy, Medicine, Vol: 39, Pages: 497-501, ISSN: 1357-3039

Women with renal disease should be counselled about the risks pregnancy may pose to them and their fetus before they conceive. Although worse baseline function and hypertension are associated with worse outcome, all women with renal disease should be advised whether their medication needs to be modified, whether they are likely to suffer irreversible renal damage, and that they have a higher risk of pre-eclampsia with its attendant risks to the fetus. They need to consider the implications of the possibility of having a premature baby. Pregnancy-induced renal disease is less common and renal failure is rare. The commonest causes are those associated with severe pre-eclampsia and are usually managed by early delivery. Proteinuria can persist for months after pre-eclampsia. Women with renal disease who present in pregnancy need to be assessed and a diagnosis made where possible. If their disease is relatively mild, they can be managed expectantly and monitored post partum. A key issue facing women who present in pregnancy is ensuring appropriate nephrological follow-up to ensure that a diagnosis is secured and a proper management plan is in place. Women with renal disease must generally be considered as having high-risk pregnancies; they need to be aware of this and to be managed in a centre with appropriate obstetric and renal expertise. © 2011 Elsevier Ltd. All rights reserved.

Journal article

Hall M, Wilkinson E, Chadna S, Farrington K, Frankel A, Greenwood R, Lightstone L, Roderick P, Willis J, Feehally J, Randhawa Get al., 2010, Ethnic differences in renal referral patterns following national CKD guidelines, CLINICAL NEPHROLOGY, Vol: 74, Pages: S152-S153, ISSN: 0301-0430

Journal article

Bramham K, Lightstone L, Taylor J, Hakim NS, Harding K, McCarthy A, Chowdhury P, Duncan N, Nelson-Piercy Cet al., 2010, Pregnancy in pancreas-kidney transplant recipients: report of three cases and review of the literature., Obstet Med, Vol: 3, Pages: 73-77, ISSN: 1753-495X

Seventy-three pregnancies in 43 women with SPK have now been described by the US National Transplantation Pregnancy Registry (NTPR) (established in 1991), which contains self-reported data from questionnaires and hospital records. These women have high rates of complications despite normoglycaemia and restoration of renal function. We describe the pregnancies of three SPK recipients in the UK managed in joint renal obstetric clinics and discuss the antenatal and postnatal complications specific to SPK transplants.

Journal article

Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, Gale DP, Wass MN, Ahmadi KR, Bakker SJL, Beckmann J, Bilo HJG, Bochud M, Brown MJ, Caulfield MJ, Connell JMC, Cook HT, Cotlarciuc I, Smith GD, de Silva R, Deng G, Devuyst O, Dikkeschei LD, Dimkovic N, Dockrell M, Dominiczak A, Ebrahim S, Eggermann T, Farrall M, Ferrucci L, Floege J, Forouhi NG, Gansevoort RT, Han X, Hedblad B, van der Heide JJH, Hepkema BG, Hernandez-Fuentes M, Hypponen E, Johnson T, de Jong PE, Kleefstra N, Lagou V, Lapsley M, Li Y, Loos RJF, Luan J, Luttropp K, Marechal C, Melander O, Munroe PB, Nordfors L, Parsa A, Peltonen L, Penninx BW, Perucha E, Pouta A, Prokopenko I, Roderick PJ, Ruokonen A, Samani NJ, Sanna S, Schalling M, Schlessinger D, Schlieper G, Seelen MAJ, Shuldiner AR, Sjogren M, Smit JH, Snieder H, Soranzo N, Spector TD, Stenvinkel P, Sternberg MJE, Swaminathan R, Tanaka T, Ubink-Veltmaat LJ, Uda M, Vollenweider P, Wallace C, Waterworth D, Zerres K, Waeber G, Wareham NJ, Maxwell PH, McCarthy MI, Jarvelin M-R, Mooser V, Abecasis GR, Lightstone L, Scott J, Navis G, Elliott P, Kooner JSet al., 2010, Genetic loci influencing kidney function and chronic kidney disease, NATURE GENETICS, Vol: 42, Pages: 373-375, ISSN: 1061-4036

Journal article

Lightstone L, 2010, Lupus nephritis: where are we now?, CURRENT OPINION IN RHEUMATOLOGY, Vol: 22, Pages: 252-256, ISSN: 1040-8711

Journal article

Pepper R, Griffith M, Kirwan C, Levy J, Taube D, Pusey C, Lightstone L, Cairns Tet al., 2009, Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids, NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol: 24, Pages: 3717-3723, ISSN: 0931-0509

Journal article

Doerner T, Isenberg D, Jayne D, Wiendl H, Zillikens D, Burmester Get al., 2009, Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis, AUTOIMMUNITY REVIEWS, Vol: 9, Pages: 82-89, ISSN: 1568-9972

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: limit=30&id=00163814&person=true&page=5&respub-action=search.html